Business
Australia strikes deal for new Covid pill that could be used in treatment by early 2022 – The Guardian Australia
Molnupiravir has been shown to prevent serious illness and death, although it is still in late stage clinical trials
Australia has secured 300,000 courses of molnupiravir, an antiviral capsule to treat Covid-19 that could be in use by early 2022.
The Morrison government has struck a supply agreement with MSD to provide the oral treatment if it is approved by the Therapeutic…
Continue Reading
-
General22 hours agoFederal government funding extends cohealth GP services until July 2026
-
Business23 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General6 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News21 hours agoFree flow of information vital to WHS – Proctor